United Therapeutics (UTHR) EPS (Diluted) Growth (1y) (2010 - 2026)
United Therapeutics (UTHR) EPS (Diluted) Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | -304.28% |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 1.28% |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | -15.70% |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 13.47% |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | -2,504.14% |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 30.20% |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 385.28% |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Alkermes | 8.21 Bn | 7.55 Bn | 397.90 Mn | -99.42% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 13.47% |
| Mar 31, 2026 | -12.15% |
| Dec 31, 2025 | 22.42% |
| Sep 30, 2025 | 12.12% |
| Jun 30, 2025 | 9.45% |
| Mar 31, 2025 | 7.47% |
| Dec 31, 2024 | 42.22% |
| Sep 30, 2024 | 18.61% |
| Jun 30, 2024 | 11.81% |
| Mar 31, 2024 | 27.02% |
| Dec 31, 2023 | 60.38% |
| Sep 30, 2023 | 9.58% |
| Jun 30, 2023 | 117.13% |
| Mar 31, 2023 | -3.43% |
| Dec 31, 2022 | 14.82% |
| Sep 30, 2022 | 43.76% |
| Jun 30, 2022 | -33.91% |
| Mar 31, 2022 | 724.60% |
| Dec 31, 2021 | 7.08% |
| Sep 30, 2021 | -10.95% |